Morgan Stanley analyst Bob Huang upgraded Corebridge (CRBG) to Overweight from Equal Weight with a price target of $43, up from $35. The company’s business shift toward fee-based earnings within group insurance will alleviate outflows, and subsequently boost fee related earnings, the analyst tells investors in a research note. The firm says this will position Corebridge “defensively in a less favorable interest rate environment.” Corebridge is demonstrating its ability to “pull on and off levers,” contends Morgan Stanley.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Strategic Adaptability and Growth Potential Drive Corebridge Financial’s Buy Rating
- Corebridge price target raised to $38 from $35 at Wells Fargo
- Corebridge Financial Reports Strong 2024 Earnings Growth
- Corebridge Financial Shines in Earnings Call
- Corebridge Financial, Inc.: Strong Q4 Performance and Strategic Capital Management Support Buy Rating